Clinical breakpoints have not been established for mold testing. Wild-type (WT) MIC distributions (organisms in a species/drug combination with no detectable acquired resistance mechanisms) were defined in order to establish epidemiologic cutoff values (ECVs) for five Aspergillus spp. and itraconazole, posaconazole, and voriconazole. Also, we have expanded prior ECV data for Aspergillus fumigatus. The number of available isolates varied according to the species/triazole combination as follows: 1,684 to 2,815 for A. fumigatus, 323 to 592 for A. flavus, 131 to 143 for A. nidulans, 366 to 520 for A. niger, 330 to 462 for A. terreus, and 45 to 84 for A. versicolor. CLSI broth microdilution MIC data gathered in five independent laboratories in E...
Azole resistance in Aspergillus fumigatus is most frequently conferred by mutations in the cyp51A ge...
The CLSI epidemiological cutoff values (ECVs) of antifungal agents are available for various Candida...
OBJECTIVES: To determine the MIC distributions of itraconazole, voriconazole and posaconazole and no...
Although clinical breakpoints have not been established for mold testing, epidemiological cutoff val...
Clinical breakpoints have not been established for mold testing. Epidemiologic cutoff values (ECVs) ...
Although clinical breakpoints have not been established for mold testing, epidemiological cutoff val...
Clinical breakpoints have not been established for mold testing. Wild-type (WT) MIC distributions (o...
Epidemiological cutoff values (ECVs) were established for the new triazole isavuconazole and Aspergi...
In the absence of clinical breakpoints, epidemiological cutoff values (ECVs) have been established t...
Although epidemiological cutoff values (ECVs) have been established for Candida spp. and the triazol...
Epidemiological cutoff values (ECV) are commonly used to separate wild-type isolates from isolates w...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Estimating epidemiological cutoff endpoints (ECVs/ECOFFS) may be hindered by the overlap of MICs for...
Estimating epidemiological cutoff endpoints (ECVs/ECOFFS) may be hindered by the overlap of MICs for...
Azole resistance in Aspergillus fumigatus is most frequently conferred by mutations in the cyp51A ge...
The CLSI epidemiological cutoff values (ECVs) of antifungal agents are available for various Candida...
OBJECTIVES: To determine the MIC distributions of itraconazole, voriconazole and posaconazole and no...
Although clinical breakpoints have not been established for mold testing, epidemiological cutoff val...
Clinical breakpoints have not been established for mold testing. Epidemiologic cutoff values (ECVs) ...
Although clinical breakpoints have not been established for mold testing, epidemiological cutoff val...
Clinical breakpoints have not been established for mold testing. Wild-type (WT) MIC distributions (o...
Epidemiological cutoff values (ECVs) were established for the new triazole isavuconazole and Aspergi...
In the absence of clinical breakpoints, epidemiological cutoff values (ECVs) have been established t...
Although epidemiological cutoff values (ECVs) have been established for Candida spp. and the triazol...
Epidemiological cutoff values (ECV) are commonly used to separate wild-type isolates from isolates w...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Clinical breakpoints (CBPs) have not been established for the Mucorales and any antifungal agent. In...
Estimating epidemiological cutoff endpoints (ECVs/ECOFFS) may be hindered by the overlap of MICs for...
Estimating epidemiological cutoff endpoints (ECVs/ECOFFS) may be hindered by the overlap of MICs for...
Azole resistance in Aspergillus fumigatus is most frequently conferred by mutations in the cyp51A ge...
The CLSI epidemiological cutoff values (ECVs) of antifungal agents are available for various Candida...
OBJECTIVES: To determine the MIC distributions of itraconazole, voriconazole and posaconazole and no...